PharmAla Biotech and Shaman Pharma Granted First Ever Special Access Program Authorization for MDMA
This authorization is the first authorized treatment of a patient with MDMA outside of a clinical trial in Canadian historyVANCOUVER, British Columbia, May 16, 2023 -- PharmAla Biotech Holdings... | May 16, 2023